Japan · Delayed Price · Currency is JPY Japan Lifeline Company Description
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan.
The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles.
Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices.
The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires.
Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 1981 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,250 |
| CEO | Keisuke Suzuki |
Contact Details
Address: Tennoz Ocean Square Tokyo Japan | |
| Phone | 81 3 6711 5200 |
Stock Details
| Ticker Symbol | 7575 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3754500001 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Keisuke Suzuki | Chief Executive Officer |
| Tatsuya Murase | Chief Operating Officer |